biocon-pharma-gets-dcgi-nod-for-diabetes-drug-liraglutide-in-india News in Hindi -1 News Headlines Found

Biocon Pharma gets DCGI nod for diabetes drug liraglutide in India

New Delhi, June 3 (UNI) Biocon Pharma Limited, a biopharmaceutical firm, on Tuesday said that drug regulator, Drugs Controller General of India under the CDSCO (Central Drugs Standard Control Organisation) has given nod to its liraglutide drug for Indian market.

#Biocon Pharma gets DCGI nod for diabetes drug liraglutide in India

biocon pharma gets dcgi nod for diabetes drug liraglutide in india- Latest Hindi News headlines on biocon pharma gets dcgi nod for diabetes drug liraglutide in india. Stay updated with recent developments & news stories about biocon pharma gets dcgi nod for diabetes drug liraglutide in india